COVID-19 and immune suppressed patients

This two-day meeting will cover the latest advances within dermatology, gastroenterology and rheumatology, including state-of-the-art lectures of the underlying immunopathology, latest treatment options and experience exchange across medical specialties. During the meeting there will be cross-therapeutic area sessions to discuss clinically relevant topics such as current treatment practices and complex patient cases.

Learning objectives

Objective of the meeting is to provide participants with the latest practical and theoretical clinical and scientific knowledge in immune-mediated inflammatory diseases and how they best should be managed.

After the meeting participants should be able to:

• Acknowledge the immunopathology driving the immune-mediated inflammatory diseases psoriasis, psoriatic arthritis and inflammatory bowel disease
• Be up-to-date with the latest advances in management of these diseases
• Be familiar with the systemic aspects of the immune-mediated inflammatory diseases and their comorbidities
• Understand the benefit of inter-specialty management of patients with immune-mediated inflammatory diseases

Scientific committee

• Charlotte Hedin, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
• Vilija Oke, Karolinska Institutet, Center for Rheumatology, Stockholm, Sweden
• Enikö Sonkoly, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
• Mona Ståhle, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
• Elisabet Svenungsson, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

Faculty

• Judith Bruchfeld, Sweden
• Helena Hervius Askling, Sweden